We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Intranasal Therapeutic Strategies for Mitigation of Airborne Microplastic and Nanoplastic Exposure
AI summary Read the abstract
This technical note outlines a proposed nasal treatment platform aimed at inhaled plastic particles, prompted by reports of microplastics in the human olfactory bulb. It is a concept, with no experiments reported. Safety and usefulness remain to be evaluated.
Airborne microplastics (MPs) and nanoplastics (NPs) are increasingly recognized as an important route of environmental exposure. Recent studies have identified microplastics within the human olfactory bulb and have demonstrated associations between environmental particulate exposure, inflammation, oxidative stress, and neurological injury. These findings suggest that the nasal cavity may represent an important site for therapeutic intervention. This Technical Note outlines a proposed intranasal therapeutic platform designed to support nasal mucosal health while mitigating biological interactions associated with inhaled environmental particles. The platform is intended to provide a flexible foundation for future pharmaceutical development through local anti-inflammatory effects, mucosal protection, barrier formation, particle interaction, and enhancement of mucociliary clearance. Additional studies will be required to evaluate safety, mechanism of action, and clinical utility.
More Papers Like This
Intranasal Therapeutic Strategies for Mitigation of Airborne Microplastic and Nanoplastic Exposure
AI summary Read the abstract
A technical note proposing an intranasal treatment platform for inhaled micro- and nanoplastics. The proposal cites findings of microplastics in the human olfactory bulb. No test results are reported, and the authors say safety, mechanism and clinical usefulness still need study.
Inhaled Microplastics and Nanoplastics: Brain Exposure via the Olfactory Pathway and Emerging Therapeutic Opportunities
AI summary Read the abstract
Researchers outline how inhaled micro- and nanoplastics can travel from the nasal cavity directly to the brain via the olfactory pathway, and propose emerging countermeasures including nasal sequestration systems and lipid nanoparticle therapeutics to address particulate burden beyond conventional masks and filtration.
Inhaled Microplastics and Nanoplastics: Brain Exposure via the Olfactory Pathway and Emerging Therapeutic Opportunities
AI summary Read the abstract
Researchers reviewed how inhaled airborne microplastics and nanoplastics can translocate from the nasal cavity directly to the brain via the olfactory pathway, and outlined potential therapeutic strategies — including nasal sequestration agents, lung-targeted approaches, and lipid nanoparticle drug delivery — to complement physical barriers in high-exposure settings.
Airborne Microplastics and Nanoplastics: Inhalation Exposure and the Case for Field-Deployable Monitoring
AI summary Read the abstract
Tiny plastic particles floating in the air we breathe may be more concerning than we thought — scientists have even found microplastics in human brain tissue (specifically the olfactory bulb, which connects your nose to your brain). This paper doesn't present new experiments; instead, it reviews why we urgently need better, portable tools to measure these airborne plastics, since current methods aren't well-suited for tracking this potential health risk in real-world settings like homes, schools, or workplaces.
Detection of microplastics in human nasal mucosa
AI summary Read the abstract
Microplastic particles were detected for the first time in human nasal mucosa samples, with polymer types and concentrations quantified, providing direct evidence that the upper respiratory tract is a site of microplastic deposition from inhaled air.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.